Odysight.ai secures Honeywell aerospace component order
Odysight.ai (NASDAQ:ODYS) received a Honeywell Aerospace order to test its predictive platform across 10,000 auxiliary power units.
Odysight.ai (NASDAQ:ODYS) received a Honeywell Aerospace order to test its predictive platform across 10,000 auxiliary power units.
Sagtec Global (NASDAQ:SAGT) issued its financial outlook for fiscal year 2026, projecting total revenue of US$25.8 million.
GRI Bio (NASDAQ:GRI) received FDA Orphan Drug Designation for its idiopathic pulmonary fibrosis drug candidate, GRI-0621.
IM Cannabis (NASDAQ:IMCC) announced on June 18, 2026, that it has entered into a non-binding letter of intent to sell its European-focused subsidiary, IMC Holdings, to Slil.com Holding.
The Allstate Corporation (NYSE:ALL) reported estimated catastrophe losses of $289 million, or $228 million after-tax, for the month of May.
Lennox (NYSE:LII) has executed a definitive agreement to acquire Heat Controller, a North American supplier of heating and cooling equipment.
Centrus Energy (NYSE:LEU) and Oklo (NYSE:OKLO) announced a letter of intent for the supply of domestic HALEU to power up to five Aurora powerhouses over multiple years.
Beam Therapeutics (NASDAQ:BEAM) announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for BEAM-304.
Deluxe (NYSE:DLX) announced on June 18, 2026, that it has reached a definitive agreement to acquire Celero Commerce, a financial technology firm focused on payment solutions for small and medium-sized businesses, for $625 million.
Novocure (NASDAQ:NVCR) announced that its Phase 3 TRIDENT trial evaluating Tumor Treating Fields (TTFields) therapy for glioblastoma did not achieve a statistically significant improvement in overall survival.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy